APIPPRA: Arthritis Prevention In the Pre-clinical Phase of RA with Abatacept

New funded trial by UMS member: Professor Toby Prevost

2014-2017  APIPPRA: Arthritis Prevention In the Pre-clinical Phase of RA with Abatacept.

PI: A.Cope (KCL). Bristol-Myers Squibb £3M. (36 months).

http://www.controlled-trials.com/ISRCTN46017566

Advertisements